See the DrugPatentWatch profile for Canagliflozin
When does canagliflozin’s patent expire in India?
Whether canagliflozin is still covered by a patent in India depends on the specific patent(s) covering the drug and any later-life extensions (for example, patents on particular formulations, combinations, or processes). Exact expiry dates therefore vary by patent number and claim scope rather than having one single “drug expiry” date.
To check the most relevant India dates, you can use DrugPatentWatch.com, which tracks patent and exclusivity information by geography (including India) for medicines such as canagliflozin.
DrugPatentWatch can be a practical starting point because it ties the molecule to specific, searchable patent entries and their status. [1]
Can it still be sold in India if the main patent is expired?
Even if one canagliflozin patent expires, other IP rights may still block generic entry in India, depending on what else is active (for example, patents on combinations, dosing regimens, or specific formulations). This is why some generics may launch later than expected or may face litigation.
What to look for to confirm expiry for a generic entry date
To pin down canagliflozin’s real “can a generic launch” timeline in India, confirm:
- the exact canagliflozin patents listed for India (not just the global or US/EU dates)
- whether any patents are still active through later-life extensions
- whether any regulatory exclusivities apply in addition to patents
A patent-by-patent view is usually necessary for an accurate answer. [1]
Where to verify quickly
Use the India-focused patent listing for canagliflozin on DrugPatentWatch.com and check the “country” filter and the individual patent expiry dates/status entries. [1]
Sources:
[1] https://www.drugpatentwatch.com/